Research Article Details

Article ID: A15334
PMID: 28963767
Source: Liver Int
Title: Body mass index trajectories in young adulthood predict non-alcoholic fatty liver disease in middle age: The CARDIA cohort study.
Abstract: BACKGROUND & AIMS: Non-alcoholic fatty liver disease is an epidemic. Identifying modifiable risk factors for non-alcoholic fatty liver disease development is essential to design effective prevention programmes. We tested whether 25-year patterns of body mass index change are associated with midlife non-alcoholic fatty liver disease. METHODS: In all, 4423 participants from Coronary Artery Risk Development in Young Adults, a prospective population-based biracial cohort (age 18-30), underwent body mass index measurement at baseline (1985-1986) and 3 or more times over 25&#160;years. At Year 25, 3115 had liver fat assessed by non-contrast computed tomography. Non-alcoholic fatty liver disease was defined as liver attenuation &#8804;40 Hounsfield Units after exclusions. Latent mixture modelling identified 25-year trajectories in body mass index per cent change (%&#916;) from baseline. RESULTS: We identified four distinct trajectories of BMI%&#916;: stable (26.2% of cohort, 25-year BMI %&#916;&#160;=&#160;3.1%), moderate increase (46.0%, BMI%&#916;&#160;=&#160;21.7%), high increase (20.9%, BMI%&#916;&#160;=&#160;41.9%) and extreme increase (6.9%, BMI%&#916;&#160;=&#160;65.9%). Y25 non-alcoholic fatty liver disease prevalence was higher in groups with greater BMI %&#916;: 4.1%, 9.3%, 13.0%, and 17.6%, respectively (P-trend <.0001). In multivariable analyses, participants with increasing BMI%&#916; had increasingly greater odds of non-alcoholic fatty liver disease compared to the stable group: OR: 3.35 (95% CI: 2.07-5.42), 7.80 (4.60-13.23) and 12.68 (6.68-24.09) for moderate, high and extreme body mass index increase, respectively. Associations were only moderately attenuated when adjusted for baseline or Y25 body mass index. CONCLUSIONS: Trajectories of weight gain during young adulthood are associated with greater non-alcoholic fatty liver disease prevalence in midlife independent of metabolic covariates and baseline or concurrent body mass index highlighting the importance of weight maintenance throughout adulthood as a target for primary non-alcoholic fatty liver disease prevention.
DOI: 10.1111/liv.13603